乳腺癌临床病理特征对预后判断的价值

    The value of the clinicopathological features of breast cancer in the judgement of the prognosis of patients

    • 摘要: 目的:分析乳腺癌患者术后临床病理学特征、治疗以及预后,探讨其预后的影响因素。方法:收集338例可手术的经病理证实的乳腺癌患者的临床及病理学资料,回顾性分析其临床及病理学特征、复发转移及生存情况,通过生存分析研究预后相关因素。结果:患者的随访时间为4~115个月,中位随访时间42个月,患者术后5年无病生存(DFS)率为77.46%,5年总生存(OS)率为81.69%。单因素分析结果显示,影响患者DFS及OS的因素包括:肿瘤大小、淋巴结转移数目以及放疗(P<0.01),多因素分析结果显示肿瘤大小以及淋巴结转移数目是乳腺癌患DFS和OS的独立影响因素(P<0.01)。结论:肿瘤大小和淋巴结转移数目是影响乳腺癌患者预后的独立危险因素。

       

      Abstract: Objective: To analyze the clinicopathological features,treatment and prognosis of patients with breast cancer,and investigate the influencing factors of prognosis.Methods: The clinical data of the clinicopathological characteristics,recurrence,metastasis and survival in 338 breast cancer patients diagnosed by pathology were retrospectively analyzed,and the influencing prognosis factor was investigated by survival analysis.Results: All patients were followed up for 4 to 115 months,and the median follow-up time was 42 months.The 5-year disease-free survival(DFS) and 5-year overall survival(OS) rates were 77.46% and 81.69%,respectively.The univariate analysis indicated that the tumor size,number of lymph node metastasis and radiotherapy were the influencing factors of DFS and OS(P<0.01).The multivariate Cox regression analysis indicated that the tumor size and number of lymph node metastasis were the independent influencing factor of DFS and OS in breast cancer pateints.Conclusions: The tumor size and number of lymph node metastasis are the independent influencing factor of prognosis in patients with breast cancer.

       

    /

    返回文章
    返回
    Baidu
    map